Cargando…

Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis

BACKGROUND: End-stage liver disease is a common cause of morbidity and mortality worldwide, yet little is known about its symptomatology and impact on health-related quality of life. AIM: To describe symptom prevalence and health-related quality of life of patients with end-stage liver disease to im...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jen-Kuei, Hepgul, Nilay, Higginson, Irene J, Gao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291907/
https://www.ncbi.nlm.nih.gov/pubmed/30345878
http://dx.doi.org/10.1177/0269216318807051
_version_ 1783380303030517760
author Peng, Jen-Kuei
Hepgul, Nilay
Higginson, Irene J
Gao, Wei
author_facet Peng, Jen-Kuei
Hepgul, Nilay
Higginson, Irene J
Gao, Wei
author_sort Peng, Jen-Kuei
collection PubMed
description BACKGROUND: End-stage liver disease is a common cause of morbidity and mortality worldwide, yet little is known about its symptomatology and impact on health-related quality of life. AIM: To describe symptom prevalence and health-related quality of life of patients with end-stage liver disease to improve care. DESIGN: Systematic review. DATA SOURCES: We searched eight electronic databases from January 1980 to June 2018 for studies investigating symptom prevalence or health-related quality of life of adult patients with end-stage liver disease. No language restrictions were applied. Meta-analyses were performed where appropriate. RESULTS: We included 80 studies: 35 assessing symptom prevalence, 41 assessing health-related quality of life, and 4 both. The instruments assessing symptoms varied across studies. The most frequently reported symptoms were as follows: pain (prevalence range 30%–79%), breathlessness (20%–88%), muscle cramps (56%–68%), sleep disturbance (insomnia 26%–77%, daytime sleepiness 29.5%–71%), and psychological symptoms (depression 4.5%–64%, anxiety 14%–45%). Erectile dysfunction was prevalent (53%–93%) in men. The health-related quality of life of patients with end-stage liver disease was significantly impaired when compared to healthy controls or patients with chronic liver disease. Compared with compensated cirrhosis, decompensation led to significant worsening of both components of the 36-Item Short Form Survey although to a larger degree for the Physical Component Summary score (decrease from average 6.4 (95% confidence interval: 4.0–8.8); p < 0.001) than for the Mental Component Summary score (4.5 (95% confidence interval: 2.4–6.6); p < 0.001). CONCLUSION: The symptom prevalence of patients with end-stage liver disease resembled that of patients with other advanced conditions. Given the diversity of symptoms and significantly impaired health-related quality of life, multidisciplinary approach and timely intervention are crucial.
format Online
Article
Text
id pubmed-6291907
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-62919072018-12-26 Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis Peng, Jen-Kuei Hepgul, Nilay Higginson, Irene J Gao, Wei Palliat Med Review Articles BACKGROUND: End-stage liver disease is a common cause of morbidity and mortality worldwide, yet little is known about its symptomatology and impact on health-related quality of life. AIM: To describe symptom prevalence and health-related quality of life of patients with end-stage liver disease to improve care. DESIGN: Systematic review. DATA SOURCES: We searched eight electronic databases from January 1980 to June 2018 for studies investigating symptom prevalence or health-related quality of life of adult patients with end-stage liver disease. No language restrictions were applied. Meta-analyses were performed where appropriate. RESULTS: We included 80 studies: 35 assessing symptom prevalence, 41 assessing health-related quality of life, and 4 both. The instruments assessing symptoms varied across studies. The most frequently reported symptoms were as follows: pain (prevalence range 30%–79%), breathlessness (20%–88%), muscle cramps (56%–68%), sleep disturbance (insomnia 26%–77%, daytime sleepiness 29.5%–71%), and psychological symptoms (depression 4.5%–64%, anxiety 14%–45%). Erectile dysfunction was prevalent (53%–93%) in men. The health-related quality of life of patients with end-stage liver disease was significantly impaired when compared to healthy controls or patients with chronic liver disease. Compared with compensated cirrhosis, decompensation led to significant worsening of both components of the 36-Item Short Form Survey although to a larger degree for the Physical Component Summary score (decrease from average 6.4 (95% confidence interval: 4.0–8.8); p < 0.001) than for the Mental Component Summary score (4.5 (95% confidence interval: 2.4–6.6); p < 0.001). CONCLUSION: The symptom prevalence of patients with end-stage liver disease resembled that of patients with other advanced conditions. Given the diversity of symptoms and significantly impaired health-related quality of life, multidisciplinary approach and timely intervention are crucial. SAGE Publications 2018-10-22 2019-01 /pmc/articles/PMC6291907/ /pubmed/30345878 http://dx.doi.org/10.1177/0269216318807051 Text en © The Author(s) 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review Articles
Peng, Jen-Kuei
Hepgul, Nilay
Higginson, Irene J
Gao, Wei
Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis
title Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis
title_full Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis
title_fullStr Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis
title_full_unstemmed Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis
title_short Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis
title_sort symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291907/
https://www.ncbi.nlm.nih.gov/pubmed/30345878
http://dx.doi.org/10.1177/0269216318807051
work_keys_str_mv AT pengjenkuei symptomprevalenceandqualityoflifeofpatientswithendstageliverdiseaseasystematicreviewandmetaanalysis
AT hepgulnilay symptomprevalenceandqualityoflifeofpatientswithendstageliverdiseaseasystematicreviewandmetaanalysis
AT higginsonirenej symptomprevalenceandqualityoflifeofpatientswithendstageliverdiseaseasystematicreviewandmetaanalysis
AT gaowei symptomprevalenceandqualityoflifeofpatientswithendstageliverdiseaseasystematicreviewandmetaanalysis